# Jasper Therapeutics, Inc.: Form 8-K, filed Nov 9, 2023

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2023-11-09
- Accepted by EDGAR: Nov 9, 2023, 08:05 ET
- Period: 2023-11-09
- Accession: 0001213900-23-084938
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390023084938/ea187963-8k_jasper.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390023084938/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390023084938/ea187963-8k_jasper.htm

Filed Nov 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-084938. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
